HIV-1
Clinical trials for HIV-1 explained in plain language.
Never miss a new study
Get alerted when new HIV-1 trials appear
Sign up with your email to follow new studies for HIV-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test antibody duo to shrink HIV hideouts
Disease control OngoingThis study is testing if two experimental antibody drugs are safe and can reduce the amount of hidden, dormant HIV in the body. The trial involves 105 adults with HIV who are on stable antiretroviral therapy. Participants receive three infusions of either the antibodies or a plac…
Matched conditions: HIV-1
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Early HIV vaccine trial paused for safety review
Disease control TerminatedThis early-stage study is testing the safety and immune response of a new HIV vaccine in adults who are already living with HIV and taking medication to control it. The goal is to see if the vaccine can help the body's immune system better fight the virus. The trial is currently …
Matched conditions: HIV-1
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Lifeline extended: HIV drug access trial keeps treatment flowing for kids and adults
Disease control OngoingThis trial provides continued access to the HIV medication etravirine for children (aged 2+) and adults who successfully completed a previous study with the drug and are still benefiting from it. The goal is to supply the medication until participants can switch to a commercially…
Matched conditions: HIV-1
Phase: PHASE3 • Sponsor: Janssen Sciences Ireland UC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC